Nia Therapeutics

Allston, MA · Founded 2016 · Privately Held (backing)

Developer of a neurostimulation device designed to stimulate memory for patients with traumatic brain injury. Nia Therapeutics is based in Allston, MA and was founded in 2016. It was valued at $69 million at its seed round in Jun 2025, the last priced event on record. It has raised $22 million across 1 recorded round; the latest was a $23.6 million early-stage round in Dec 2021.

PMV mark · valuation
$69.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$22.0M
Last round
Early Stage VC
Dec 2021
What is Nia Therapeutics worth?
$69.0MPrivateMarketView mark · Oct 2026

Valued at $69.0M at its seed round, Jun 2025. Nothing has traded since.

Free account
More of Nia Therapeutics with a free account
  • ·Watch Nia Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Nia Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Dec 2021Early Stage VC$23.6M▮
Unlock post-money valuations

Membership and data by Private Market View

Nia Therapeutics valuation

Nia Therapeutics was valued at $69 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Nia Therapeutics raised?

Nia Therapeutics has raised $22 million across 1 recorded round since 2021. The largest was a $23.6 million early-stage round in Dec 2021.

Nia Therapeutics has filed 2 Form Ds with the SEC since 2025, most recently in Mar 2026 ($18.8 million sold to 33 investors).

How Nia Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Nia Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Nia Therapeutics

What is Nia Therapeutics worth?
Nia Therapeutics is valued at $69.0M as of Oct 2026. Valued at $69.0M at its seed round, Jun 2025. Nothing has traded since.
How much has Nia Therapeutics raised?
Nia Therapeutics has raised $22.0M in total funding across 1 recorded rounds.
When did Nia Therapeutics last raise?
Nia Therapeutics last raised in Dec 2021 (Early Stage VC), raising $23.6M.